Quantrx Biomedical Corp (QTXB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -260 | -253 | -622 | -737 | 869 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 11 |
| Accounts payable and accrued liabilities | -6 | -21 | 7 | -12 | 20 |
| Other Working Capital | 211 | 202 | 208 | 210 | 249 |
| Other Operating Activity | 6 | -3 | 215 | 281 | -1,299 |
| Operating Cash Flow | $-50 | $-75 | $-192 | $-258 | $-151 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | 201 | 497 |
| Other Investing Activity | 0 | 0 | 0 | 201 | 497 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $201 | $497 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 115 |
| Debt Repayment | N/A | N/A | N/A | N/A | -2 |
| Other Financing Activity | 0 | 0 | 0 | -81 | 0 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-81 | $113 |
| Beginning Cash Position | 55 | 130 | 322 | 460 | 1 |
| End Cash Position | 6 | 55 | 130 | 322 | 460 |
| Net Cash Flow | $-50 | $-75 | $-192 | $-138 | $459 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50 | -75 | -192 | -258 | -151 |
| Free Cash Flow | -50 | -75 | -192 | -258 | -151 |